We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.5B
1-Year Est. Return 33.95%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$1.6B
AUM Growth
+$312M
Cap. Flow
+$307M
Cap. Flow %
19.14%
Top 10 Hldgs %
22.85%
Holding
1,549
New
435
Increased
314
Reduced
316
Closed
482

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$12.6M
2
CCI icon
Crown Castle
CCI
+$7.91M
3
LLY icon
Eli Lilly
LLY
+$7.58M
4
RTX icon
RTX Corp
RTX
+$7.28M
5
DE icon
Deere & Co
DE
+$7.24M

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.16%
2 Consumer Discretionary 11.77%
3 Financials 11.5%
4 Healthcare 9.84%
5 Technology 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGN icon
1076
Align Technology
ALGN
$10.4B
-18,407
Closed -$1.34M
ALKS icon
1077
Alkermes
ALKS
$7.72B
-13,400
Closed -$458K
ALLE icon
1078
Allegion
ALLE
$13.1B
-15,100
Closed -$962K
ALNY icon
1079
Alnylam Pharmaceuticals
ALNY
$31.9B
-8,000
Closed -$502K
AMBA icon
1080
Ambarella
AMBA
$2.84B
-48,735
Closed -$2.18M
AMC icon
1081
AMC Entertainment Holdings
AMC
$2.28B
-1,180
Closed -$330K
AMCX icon
1082
AMC Global Media
AMCX
$503M
-18,087
Closed -$1.18M
AMGN icon
1083
Amgen
AMGN
$203B
-10,135
Closed -$1.52M
AMKR icon
1084
Amkor Technology
AMKR
$11.5B
-10,900
Closed -$64K
AMP icon
1085
Ameriprise Financial
AMP
$49.4B
-7,122
Closed -$670K
ANIP icon
1086
ANI Pharmaceuticals
ANIP
$1.66B
-18,645
Closed -$628K
ANSS
1087
DELISTED
Ansys
ANSS
-7,920
Closed -$709K
AOS icon
1088
A.O. Smith
AOS
$7.78B
-27,892
Closed -$1.06M
ARI
1089
Apollo Commercial Real Estate
ARI
$837M
-16,400
Closed -$267K
ARR
1090
Armour Residential REIT
ARR
$2.13B
-2,100
Closed -$226K
ATO icon
1091
Atmos Energy
ATO
$27.4B
-15,513
Closed -$1.15M
ATR icon
1092
AptarGroup
ATR
$7.93B
-6,305
Closed -$494K
ATRA icon
1093
Atara Biotherapeutics
ATRA
$94.8M
-648
Closed -$308K
AUB icon
1094
Atlantic Union Bankshares
AUB
$5.7B
-9,600
Closed -$236K
AVXL icon
1095
Anavex Life Sciences
AVXL
$226M
-21,900
Closed -$107K
AWK icon
1096
American Water Works
AWK
$27.4B
-9,919
Closed -$684K
AXON
1097
Axon Enterprise
AXON
$35.9B
-17,567
Closed -$345K
AZZ icon
1098
AZZ Inc
AZZ
$4B
-5,313
Closed -$301K
BCO icon
1099
Brink's
BCO
$4.48B
-6,153
Closed -$207K
BCRX icon
1100
BioCryst Pharmaceuticals
BCRX
$2.09B
-41,197
Closed -$117K

Similar funds

Squarepoint's Q2 2016 Portfolio in Review

As of Q2 2016, Squarepoint held 1,549 positions worth $1.6B, up 24% from $1.29B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Squarepoint deployed $307M of net new capital in Q2 2016, opening 435 new positions and adding to 314 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Crown Castle, an estimated $7.91M trimmed.

  • Squarepoint's largest Q2 2016 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
  • Squarepoint added most to CVS Health in Q2 2016, an estimated $18.9M increase.
  • Squarepoint's biggest Q2 2016 reduction was Crown Castle, cutting an estimated $7.91M.
  • Squarepoint fully exited Chubb in Q2 2016, selling an estimated $12.6M.
  • Squarepoint's ten largest holdings make up 23% of its $1.6B portfolio in Q2 2016.
  • Squarepoint opened 435 new positions and closed 482 in Q2 2016.
  • Squarepoint's portfolio value rose 24% quarter-over-quarter to $1.6B.

Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.